YIV-906

PHY906 · Yiviva Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YIV-906, covering 2025-04-13 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC) [Phase 2]